Department of Endocrinology St Olavs Hospital, Trondheim University Hospital P O Box 3250 Sluppen, N-7006, Trondheim Norway ; Department of Public Health Norwegian University of Science and Technology N-7491, Trondheim Norway.
Endocr Connect. 2012 Aug 30;1(2):62-7. doi: 10.1530/EC-12-0047. Print 2012 Nov 1.
It has been suggested that comparison of posttest dexamethasone and cortisol concentrations may improve the evaluation of the dexamethasone suppression test (DST) for Cushing's syndrome. In particular, this would be reasonable if posttest cortisol differs by dexamethasone levels within the range that is usually attained in the DST. Using fractional polynomial regression, we therefore studied the association between posttest 0800 h dexamethasone and cortisol levels in 53 subjects without Cushing's syndrome who were tested with the 1 mg overnight DST. Plasma dexamethasone was associated with plasma cortisol (P<0.001), and the regression line suggested a strong negative association related to dexamethasone levels <5 nmol/l. However, among the 94% of subjects with plasma dexamethasone >5.0 nmol/l, there was no association between dexamethasone and cortisol levels (P=0.55). In conclusion, subjects tested with the 1 mg overnight DST usually attain an 0800 h plasma dexamethasone >5 nmol/l, and plasma cortisol does not differ by plasma dexamethasone in these subjects. This suggests that routine comparison of dexamethasone and cortisol levels may not be a useful approach to improve the performance of the 1 mg DST. However, dexamethasone measurements may identify subjects with inadequately low plasma dexamethasone and may therefore be of value when retesting subjects with possibly false-positive DST results.
有人提出,比较地塞米松抑制试验(DST)后的地塞米松和皮质醇浓度可能有助于评估库欣综合征。如果 DST 中通常达到的地塞米松水平范围内的皮质醇在后测时有所不同,这将是合理的。因此,我们使用分数多项式回归,研究了 53 例无库欣综合征患者在进行 1mg 过夜 DST 后 0800h 地塞米松和皮质醇水平之间的关联。血浆地塞米松与皮质醇相关(P<0.001),回归线表明与地塞米松水平<5nmol/l 相关的强烈负相关。然而,在 94%的血浆地塞米松>5.0nmol/l 的患者中,地塞米松和皮质醇水平之间没有关联(P=0.55)。总之,接受 1mg 过夜 DST 检查的患者通常在 0800h 时达到血浆地塞米松>5nmol/l,并且在这些患者中,血浆皮质醇与血浆地塞米松无差异。这表明常规比较地塞米松和皮质醇水平可能不是改善 1mg DST 性能的有效方法。然而,地塞米松测量可能会识别出地塞米松水平不足的患者,因此当重新测试可能出现假阳性 DST 结果的患者时,地塞米松测量可能具有价值。